Literature DB >> 15763136

Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry.

Lynette C Daws1, Sylvia Montañez, W Anthony Owens, Georgianna G Gould, Alan Frazer, Glenn M Toney, Greg A Gerhardt.   

Abstract

High-speed chronoamperometry was used to determine the kinetics of clearance of exogenously applied serotonin (5-HT) in the dorsal raphe nucleus (DRN), dentate gyrus, CA3 region of the hippocampus or corpus callosum of anesthetized rats. Maximal velocity (Vmax) for 5-HT clearance was greatest in the DRN > dentate gyrus > CA3 > corpus callosum. Apparent affinity (K(T)) of the serotonin transporter (5-HTT) was similar in DRN and CA3 but greater in dentate gyrus and corpus callosum. A 90% loss of norepinephrine transporters (NET) produced by 6-hydroxydopamine pretreatment, resulted in a two-fold reduction in Vmax and a 30% decrease in K(T) in the dentate gyrus, but no change in kinetic parameters in the CA3 region. Pretreatment with 5,7-dihydroxytryptamine that resulted in a 90% reduction in 5-HTT density, modestly reduced Vmax in dentate gyrus but not in CA3. The same treatment had no effect on K(T) in the dentate gyrus but increased K(T) two-fold in the CA3. Neurotoxin treatments had no effect on 5-HT clearance in the corpus callosum. In hippocampal regions of intact rats, local application of the selective serotonin reuptake inhibitor, fluvoxamine, inhibited 5-HT clearance most robustly when the extracellular concentration of 5-HT was less than the K(T) value. By contrast, the NET antagonist, desipramine, significantly inhibited 5-HT clearance when extracellular concentrations of 5-HT were greater than the K(T) value. These data indicate that hippocampal uptake of 5-HT may be mediated by two processes, one with high affinity but low capacity (i.e. the 5-HTT) and the other with low affinity but a high capacity (i.e. the NET). These data show for the first time in the whole animal that 5-HT clearance in brain is regionally distinct with regard to rate and affinity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763136     DOI: 10.1016/j.jneumeth.2004.09.011

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  29 in total

1.  Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter.

Authors:  Brent J Thompson; Tammy Jessen; L K Henry; Julie R Field; Karen L Gamble; Paul J Gresch; Ana M Carneiro; Rebecca E Horton; Peter J Chisnell; Yekaterina Belova; Douglas G McMahon; Lynette C Daws; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

2.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

Review 3.  Monitoring rapid chemical communication in the brain.

Authors:  Donita L Robinson; Andre Hermans; Andrew T Seipel; R Mark Wightman
Journal:  Chem Rev       Date:  2008-06-25       Impact factor: 60.622

4.  Membrane-permeable C-terminal dopamine transporter peptides attenuate amphetamine-evoked dopamine release.

Authors:  Mattias Rickhag; William A Owens; Marie-Therese Winkler; Kristine Nørgaard Strandfelt; Mette Rathje; Gunnar Sørensen; Bjørn Andresen; Kenneth L Madsen; Trine Nygaard Jørgensen; Gitta Wörtwein; David P D Woldbye; Harald Sitte; Lynette C Daws; Ulrik Gether
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

5.  Quinine enhances the behavioral stimulant effect of cocaine in mice.

Authors:  Adriana Huertas; William D Wessinger; Yuri V Kucheryavykh; Priscila Sanabria; Misty J Eaton; Serguei N Skatchkov; Legier V Rojas; Gerónimo Maldonado-Martínez; Mikhail Y Inyushin
Journal:  Pharmacol Biochem Behav       Date:  2014-12-05       Impact factor: 3.533

6.  Serotonin synthesis, release and reuptake in terminals: a mathematical model.

Authors:  Janet Best; H Frederik Nijhout; Michael Reed
Journal:  Theor Biol Med Model       Date:  2010-08-19       Impact factor: 2.432

7.  Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices.

Authors:  Carrie E John; Sara R Jones
Journal:  Neuropharmacology       Date:  2007-03-16       Impact factor: 5.250

8.  Carbon-fiber microelectrodes for in vivo applications.

Authors:  Megan L Huffman; B Jill Venton
Journal:  Analyst       Date:  2008-10-31       Impact factor: 4.616

9.  Kinetics of the dopamine transporter in Drosophila larva.

Authors:  Trisha L Vickrey; Ning Xiao; B Jill Venton
Journal:  ACS Chem Neurosci       Date:  2013-04-26       Impact factor: 4.418

10.  Quantitative evaluation of serotonin release and clearance in Drosophila.

Authors:  Xenia Borue; Stephanie Cooper; Jay Hirsh; Barry Condron; B Jill Venton
Journal:  J Neurosci Methods       Date:  2009-03-04       Impact factor: 2.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.